Preventive Healthcare Technologies and Services Market
Preventive Healthcare Technologies and Services Market (Early Detection and Screening Technologies, Prophylaxis Technologies, Advanced Technologies to Reduce Errors and Chronic Disease Management Technologies) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020
Press Release :
Preventive Healthcare Technologies and Services Market: Snapshot
Preventive healthcare services includes measures taken for counteractive action of ailments caused either by diagnosis of the disease or vaccination. The ailments that are observed or vaccinated limitlessly are cardiovascular problems, perpetual respiratory ailment, other complications, certain contagious illnesses, and diabetes. These advancements help in aversion of sicknesses by diagnosing the infection early or vaccination. Preventive healthcare technological innovations and facilities are immensely popular due to rising rates of cardiovascular sicknesses, constant respiratory ailments, and certain prescription or dispensing mistakes. The report gives a general data and information of the worldwide preventive healthcare services and technology market in terms of market segments, drivers, restraints, advancements, benefits and in addition geographic areas.
According to the report, the global preventive healthcare technologies and services market is highly competitive and is expected to witness a significant growth rate with a strong CAGR of 9.70% within the forecast period from 2014 to 2020. In the year 2013, the market was evaluated to be around worth US$ 72.8 bn. This market value is anticipated to soar at whooping figure of US$ 144.8 bn by the end of 2020.
Supportive Government Policies to drive the Growth of Preventive Healthcare Technologies and Services Market
Helpful government strategies that are giving good condition to preventive healthcare technologies and services and expanding mindfulness and activities for prophylaxis are significant reasons that are driving the development of this market. So also, lessened medicinal services cost trouble because of entrance of preventive healthcare technologies and services and expanding interest for self-monitoring gadgets are other key elements expected to move the market development. However, high establishment and support costs have upset the entrance of preventive healthcare technologies in the developing markets of the world. Lacking patient engagement exercises have demotivated the doctors and drug specialists to embrace the innovation. The market for preventive healthcare technologies and services is to a great extent driven by the rising open mindfulness about inoculation and sickness administration, valuable government arrangements went for the improvement of social insurance IT, mechanical upgradation, and developing interest to diminish medicinal services costs.
North America to Rule Other Region Due to Technological Advancement
Based on early detection and screening technologies the market is broadly segmented into personalized medicine, prophylaxis technologies, automated screening, and other advanced screening tests. On the basis of advanced technologies to reduce errors the market is divided into electronic prescribing, automated prescription, formulation and dispensing, clinical decision support system, smart infusion pumps, computerized provider order entry systems, and smart packaging. As per flu vaccines the market is categorized into combined tetanus-diphtheria-pertussis vaccines, meningococcal vaccines, human papillomavirus vaccine, and other new vaccines. Moreover, chronic disease management technologies is segmented into glucose monitors, blood pressure monitors, asthma monitors, and cardiac monitors.
Geographically the preventive healthcare technologies and services market is divided into Europe, North America, Asia Pacific, and rest of the World (RoW). In year 2013, North America was seen to be the biggest and quickest developing business sector amid predicted time of 2014 to 2020 for preventive healthcare technologies and services. The steady repayment strategies, global center of data innovation, high mindfulness about preventive medicinal services advances and emergence of real players in this market are a portion of the main considerations supporting the development of this market in North America. Asia-Pacific and Rest of the World are expected to be potential markets in coming years, with the present market infiltration evaluated to be low.
Myriad Genetics, Inc., Dilon Technologies, Inc., Novx Systems, Inc., Viatronix, Inc., and U-Systems, Inc. are some of the key players in early detection and screening market.
This report on preventive healthcare technology and services market studies current as well as future prospects of the market globally. Preventive healthcare technologies and services market is a combination of screening, monitoring, prophylaxis and healthcare information technology having single target of disease prevention. These technologies aid in prevention of diseases by predetermination of the disease or immunization. Preventive healthcare technologies and services are high in demand owing to rising incidences of cardiovascular diseases, chronic respiratory diseases, dispensing or prescription errors, diabetes and certain infectious diseases. This report comprises an elaborate executive summary, which includes a market snapshot that provides overall information of various segments and sub-segments that are contained in the report. It also provides an overall information and data analysis of the global preventive healthcare technology and services market with respect to market segments based on technologies, services as well as geographic regions.
Preventive healthcare technologies and services market is segmented as early detection and screening technologies, prophylaxis technologies, advanced technologies to reduce errors and chronic disease management technologies. The early detection and screening technologies are further segmented as personalized medicine, automated screening technology and other advanced screening technologies. The prophylaxis market comprises influenza vaccine, meningococcal vaccine, combined tetanus-diphtheria-pertussis vaccine, human papillomavirus vaccine and other new vaccines. Advanced technologies include electronic prescribing, computerized provider order entry systems, clinical decision support systems, automated prescription, formulation and dispensing technology, smart infusion pumps and smart packaging. The chronic disease management technologies contain blood pressure monitors, glucose monitors, cardiac monitors and asthma monitors. The market for early detection and screening technologies has been analyzed based on applications of the technology, global sales of screening devices, integrated market study of personalized medicine and their geographic distribution.
The market for prophylaxis technologies has been analyzed based upon the prevalence of disease, distribution of vaccines to governmental and non-governmental bodies, pricing strategies, pipeline drugs and geographical distribution. The advanced technologies to reduce errors market has been analyzed based upon the installation patterns and costs, maintenance costs, importance of customized systems and its global market penetration. The chronic disease management technologies has been analyzed based upon the prevalence of chronic diseases, market differentiation on the basis of self-monitoring devices and commercial devices, price and geographical distribution. The market size and forecast in terms of USD million for each technology and service has been provided for the period 2012 to 2020. The report on preventive healthcare technologies and services market also provides % compounded annual growth rate (CAGR) for each market segment for the forecast period 2014 to 2020, considering 2013 as the base year.
Geographically, preventive healthcare technologies and services market has been categorized into four major regions: North America, Europe, Asia-Pacific, and Rest of the World (ROW). The market size and forecast for each of these regions have been provided for the period 2012 to 2020 along with CAGR (%) for the forecast period 2014 to 2020. The research study also incorporates competitive scenario in these regions. A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the global preventive healthcare technologies and services market and future opportunities has been provided in the market overview section. This section of the report also provides market attractiveness analysis and Porter’s five forces analysis, and key player’s market share analysis in 2013 for the preventive healthcare technologies and services market.
A list of recommendations has been provided for new entrants to help establish strong presence and for existing market players to increase market share. The report also profiles major players in the preventive healthcare technologies and services market based on various attributes such as company overview, financial overview, business strategies, product portfolio and recent developments. Major players profiled in this report include Omron Healthcare, Inc., Medtronic, Inc., Alere, Inc., Healthways, Inc., Dilon Technologies, Inc., Merck&Co. Inc. and ScriptPro LLC.
Global Preventive Healthcare Technologies and Services Market
Early Detection and Screening Technologies
- Personalized Medicine
- Automated Screening
- Other Advanced Screening Tests
- Prophylaxis Technologies
- Meningococcal Vaccines
- Combined Tetanus-Diptheria-Pertussis Vaccines
- Human Papillomavirus Vaccine
- Other new Vaccines
Advanced Technologies to Reduce Errors
- Electronic Prescribing
- Computerized Provider Order Entry Systems
- Clinical Decision Support System
- Automated Prescription, Formulation and Dispensing
- Smart Infusion Pumps
- Smart Packaging
Chronic Disease Management Technologies
- Blood Pressure Monitors
- Glucose Monitors
- Cardiac Monitors
- Asthma Monitors
Global Preventive Healthcare Technologies and Services Market, by Geography
- North America
- Rest of the World (RoW)